newsfilter
← Latest News
Business Wire·

Axcella Therapeutics to Present at the H.C. Wainwright BioConnect Conference

Axcella Therapeutics (NASDAQ:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced that President and Chief Executive Off